UOC
AVIR icon

UBS O'Connor’s Atea Pharmaceuticals AVIR Stock Holding History

UBS O'Connor’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-50,000
Closed -$1.75M – 890
2021
Q3 		$1.75M Buy
+50,000
New +$1.75M 0.01% 559